DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 4366--------------------------------------------------
       (Abst.) DMTs in pediatric-onset MS
   DIR By: agate
       Date: March 29, 2024, 11:10 am
       ---------------------------------------------------------
       These authors advocate the use of high-efficacy
       DMTs--alemtuzumab, cladribine, daclizumab, fingolimod,
       mitoxantrone, natalizumab, ocrelizumab, rituximab, or autologous
       hematopoietic stem cell transplantation--in persons diagnosed
       with MS between the ages of 15 and 24.
       From PubMed (March 29, 2024)--"Disease-modifying therapies in
       managing disability worsening in pediatric-onset multiple
       sclerosis:  A longitudinal analysis of global and national
       registries":
  HTML https://pubmed.ncbi.nlm.nih.gov/38547883/
       *****************************************************
       Page 1 of 1